# Nephrocare Health Services Ltd (NEPHROPLUS)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹607.5
Day Change: +3.77%
52W High: ₹663.9
52W Low: ₹446
Market Cap: ₹6,459 Cr

## Valuation
P/E: 90.93
P/B: 1.65
EPS: ₹7.08
Book Value: ₹391.25
Dividend Yield: 0%

## Returns
1Y Return: 0%

## Profitability
ROE: 0%
ROCE: 95.99%
Debt/Equity: 0.36
Revenue Growth: 31.7%
Profit Growth: 40.2%
EBITDA Margin: 22.99%
Operating Margin: 15.02%

## About
Nephrocare Health Services Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Nephrocare Health Services Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-18T22:58:34.337Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:34.337Z
Quant Updated: 2026-05-18T22:58:34.337Z
Sentiment Updated: 2026-05-18T22:58:34.337Z
Financials Status: current
Financials Updated: 2026-05-18T12:31:09.579Z
Financials Last Attempt: 2026-05-18T12:31:09.579Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2022)
Revenue: ₹286 Cr
Operating Profit: ₹37 Cr (OPM 13%)
Net Profit: ₹1 Cr
Tax: ₹1 Cr

## Annual P&L History
Mar 2022: Rev ₹286Cr | PAT ₹1Cr | OPM 13%
Mar 2023: Rev ₹318Cr | PAT ₹-21Cr | OPM 5%
Mar 2024: Rev ₹437Cr | PAT ₹-12Cr | OPM 11%

## Balance Sheet (Mar 2022)
Total Assets: ₹428 Cr
Total Liabilities: ₹428 Cr
Borrowings: ₹140 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%

## Board
- Vikram  Vuppala, Founder, MD & Chairman
- Rohit  Singh, Group Chief Executive Officer
- Prashant Vinodkumar Goenka, CFO & Chief Risk Officer
- Sukaran Singh Saluja, Chief Executive Officer of India & Nepal
- Sandeep  Gudibanda, Co-Founder & Director of Business Development

---
Source: rupiya.io/stocks/nephroplus
Disclaimer: For research and education only. Not investment advice.